⌘K

Home/Filings/4/0001213900-22-040317

4//SEC Filing

Davis Blaine 4

Accession 0001213900-22-040317

CIK 0001359931other

View on SEC.gov Company Profile

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 4:31 PM ET

Size

5.0 KB

Accession

0001213900-22-040317

Insider Transaction Report

Form 4

Period: 2022-07-15

Protara Therapeutics, Inc.TARA

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2022-07-15$3.13/sh−5,081$15,904→ 20,662 total

Footnotes (1)

[F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022.

Documents

1 file

4
ownership.xmlPrimary
OWENER SHIP DOCUMENT

Issuer

Protara Therapeutics, Inc.

CIK 0001359931

Entity typeother

Related Parties

1

filerCIK 0001802188

Filing Metadata

Form type: 4
Filed: Jul 18, 8:00 PM ET
Accepted: Jul 19, 4:31 PM ET
Size: 5.0 KB

View on SEC.gov